Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

Neuropace, Inc. Common Stock (NPCE)

Surgical & Medical Instruments & Apparatus

https://www.neuropace.com

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.

455 N. BERNARDO AVENUE
MOUNTAIN VIEW, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/22/2021

Market Cap

206,568,775

Shares Outstanding

26,280,000

Weighted SO

26,283,674

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

ELMD --.--%

KIDS --.--%

SRDX --.--%

FNA --.--%

NVRO --.--%

NUVA --.--%

ITGR --.--%

GKOS --.--%

CNMD --.--%

Beta

1.8100

Last Div

0.0000

Range

4.29-18.15

Chg

-0.0200

Avg Vol

109246

Mkt Cap

206568775

Exch

NASDAQ

Country

US

Phone

650 237 2700

DCF Diff

14.0132

DCF

-0.0232

Div Yield

0.0000

P/S

2.8762

EV Multiple

-12.0346

P/FV

20.6511

Div Yield %

0.0000

P/E

-6.8282

PEG

-0.4166

Payout

0.0000

Current Ratio

6.3747

Quick Ratio

5.4718

Cash Ratio

1.0206

DSO

57.1343

DIO

223.4160

Op Cycle

280.5503

DPO

45.0253

CCC

235.5250

Gross Margin

0.7415

Op Margin

-0.3450

Pretax Margin

-0.4163

Net Margin

-0.4163

Eff Tax Rate

0.1970

ROA

-0.3167

ROE

-1.9526

ROCE

-0.3029

NI/EBT

1.0000

EBT/EBIT

1.2067

EBIT/Rev

-0.3450

Debt Ratio

0.6437

D/E

6.1464

LT Debt/Cap

0.8565

Total Debt/Cap

0.8601

Int Coverage

-5.4826

CF/Debt

-0.2810

Equity Multi

9.5487

Rec Turnover

6.3885

Pay Turnover

8.1066

Inv Turnover

1.6337

FA Turnover

5.2657

Asset Turnover

0.7609

OCF/Share

-0.5916

FCF/Share

-0.5989

Cash/Share

1.9248

OCF/Sales

-0.2377

FCF/OCF

1.0122

CF Coverage

-0.2810

ST Coverage

-9.8053

CapEx Coverage

-82.0721

Div&CapEx Cov

-82.0721

P/BV

20.6511

P/B

20.6511

P/S

2.8762

P/E

-6.8282

P/FCF

-11.9549

P/OCF

-11.9581

P/CF

-11.9581

PEG

-0.4166

P/S

2.8762

EV Multiple

-12.0346

P/FV

20.6511

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 28, 22:31 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE GlobeNewswire Inc. Mar 04, 02:15 UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference Benzinga Dec 27, 10:00 Breaking Down NeuroPace: 6 Analysts Share Their Views GlobeNewswire Inc. Dec 19, 16:30 NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. Dec 04, 17:07 NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration Benzinga Nov 10, 14:34 Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position Benzinga Nov 10, 09:00 Expert Ratings for NeuroPace

Revenue Product Segmentation